Cosmo Feilding Mellen
Vorstandsvorsitzender bei Beckley Canopy Therapeutics Ltd.
Profil
Cosmo Feilding Mellen has founded Beckley Psytech Ltd.
in 1998, where he currently holds the title of Chief Executive Officer & Director.
He is also currently working as Co-Managing-Director & Director at Beckley Canopy Therapeutics Ltd.
Aktive Positionen von Cosmo Feilding Mellen
| Unternehmen | Position | Beginn |
|---|---|---|
Beckley Canopy Therapeutics Ltd.
 Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Vorstandsvorsitzender | - |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Gründer | 01.01.1998 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Beckley Canopy Therapeutics Ltd.
Beckley Canopy Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Beckley Psytech Ltd.
Beckley Psytech Ltd. Pharmaceuticals: MajorHealth Technology Beckley Psytech Ltd. operates as a psychedelic medicine company. It engages in helping patients suffering from neurological and mental health disorders by developing psychedelic compounds. The company was founded by Lady Amanda Feilding and Cosmo Feilding Mellen in 1998 and is headquartered in the United Kingdom. | Health Technology |
